From Oxiranes to Oligomers

Architectures of US FDA Approved Pharmaceuticals Containing Oxygen Heterocycles

Michael D. Delost, David Townsend Smith, Benton J. Anderson, Jon T Njardarson

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Oxygen heterocycles are the second most common type of heterocycles that appear as structural components of US Food and Drug Administration (FDA) approved pharmaceuticals. Analysis of our database of drugs approved through 2017, reveals 311 distinct pharmaceuticals containing at least one oxygen heterocycle. Most prevalent among these are pyranoses, with furanoses, macrolactones, morpholines, and dioxolanes rounding out the top five. The main body of this perspective is organized according to ring-size, commencing with three and four membered rings and ending with macrocycles, polymers, and unusual oxygen-containing heterocycles. For each section, all oxygen heterocycle containing drugs are presented along with a brief discussion about structural and drug application patterns.

Original languageEnglish (US)
JournalJournal of Medicinal Chemistry
DOIs
StateAccepted/In press - Jun 2 2018

Fingerprint

Epoxy Compounds
United States Food and Drug Administration
Oxygen
Pharmaceutical Preparations
Morpholines
Dioxolanes
Pharmaceutical Databases
Polymers

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

From Oxiranes to Oligomers : Architectures of US FDA Approved Pharmaceuticals Containing Oxygen Heterocycles. / Delost, Michael D.; Smith, David Townsend; Anderson, Benton J.; Njardarson, Jon T.

In: Journal of Medicinal Chemistry, 02.06.2018.

Research output: Contribution to journalArticle

@article{89376b26943a40cdb1cac9ebe3a2a5a3,
title = "From Oxiranes to Oligomers: Architectures of US FDA Approved Pharmaceuticals Containing Oxygen Heterocycles",
abstract = "Oxygen heterocycles are the second most common type of heterocycles that appear as structural components of US Food and Drug Administration (FDA) approved pharmaceuticals. Analysis of our database of drugs approved through 2017, reveals 311 distinct pharmaceuticals containing at least one oxygen heterocycle. Most prevalent among these are pyranoses, with furanoses, macrolactones, morpholines, and dioxolanes rounding out the top five. The main body of this perspective is organized according to ring-size, commencing with three and four membered rings and ending with macrocycles, polymers, and unusual oxygen-containing heterocycles. For each section, all oxygen heterocycle containing drugs are presented along with a brief discussion about structural and drug application patterns.",
author = "Delost, {Michael D.} and Smith, {David Townsend} and Anderson, {Benton J.} and Njardarson, {Jon T}",
year = "2018",
month = "6",
day = "2",
doi = "10.1021/acs.jmedchem.8b00876",
language = "English (US)",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",

}

TY - JOUR

T1 - From Oxiranes to Oligomers

T2 - Architectures of US FDA Approved Pharmaceuticals Containing Oxygen Heterocycles

AU - Delost, Michael D.

AU - Smith, David Townsend

AU - Anderson, Benton J.

AU - Njardarson, Jon T

PY - 2018/6/2

Y1 - 2018/6/2

N2 - Oxygen heterocycles are the second most common type of heterocycles that appear as structural components of US Food and Drug Administration (FDA) approved pharmaceuticals. Analysis of our database of drugs approved through 2017, reveals 311 distinct pharmaceuticals containing at least one oxygen heterocycle. Most prevalent among these are pyranoses, with furanoses, macrolactones, morpholines, and dioxolanes rounding out the top five. The main body of this perspective is organized according to ring-size, commencing with three and four membered rings and ending with macrocycles, polymers, and unusual oxygen-containing heterocycles. For each section, all oxygen heterocycle containing drugs are presented along with a brief discussion about structural and drug application patterns.

AB - Oxygen heterocycles are the second most common type of heterocycles that appear as structural components of US Food and Drug Administration (FDA) approved pharmaceuticals. Analysis of our database of drugs approved through 2017, reveals 311 distinct pharmaceuticals containing at least one oxygen heterocycle. Most prevalent among these are pyranoses, with furanoses, macrolactones, morpholines, and dioxolanes rounding out the top five. The main body of this perspective is organized according to ring-size, commencing with three and four membered rings and ending with macrocycles, polymers, and unusual oxygen-containing heterocycles. For each section, all oxygen heterocycle containing drugs are presented along with a brief discussion about structural and drug application patterns.

UR - http://www.scopus.com/inward/record.url?scp=85050610543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050610543&partnerID=8YFLogxK

U2 - 10.1021/acs.jmedchem.8b00876

DO - 10.1021/acs.jmedchem.8b00876

M3 - Article

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

ER -